RJFRAYMOND JAMES FINANCIAL INC

NYSE raymondjames.com


$ 123.58 $ -1.19 (-0.95 %)    

Wednesday, 22-May-2024 15:59:51 EDT
QQQ $ 454.82 $ -0.09 (-0.02 %)
DIA $ 398.57 $ -2.12 (-0.53 %)
SPY $ 530.36 $ -1.53 (-0.29 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ -4.12 (-1.84 %)
$ 123.6
$ 124.55
$ 0.00 x 0
$ 0.00 x 0
$ 122.84 - $ 125.21
$ 87.42 - $ 131.19
1,013,159
na
26.38B
$ 1.12
$ 14.89
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 02-07-2024 12-31-2023 10-Q
3 11-21-2023 09-30-2023 10-K
4 08-04-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 02-03-2023 12-31-2022 10-Q
7 11-22-2022 09-30-2022 10-K
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-08-2022 12-31-2021 10-Q
11 11-23-2021 09-30-2021 10-K
12 08-09-2021 06-30-2021 10-Q
13 05-07-2021 03-31-2021 10-Q
14 02-08-2021 12-31-2020 10-Q
15 11-24-2020 09-30-2020 10-K
16 08-07-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-07-2020 12-31-2019 10-Q
19 11-26-2019 09-30-2019 10-K
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-08-2019 12-31-2018 10-Q
23 11-21-2018 09-30-2018 10-K
24 08-07-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 02-08-2018 12-31-2017 10-Q
27 11-22-2017 09-30-2017 10-K
28 08-08-2017 08-08-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 02-08-2017 12-31-2016 10-Q
31 11-22-2016 09-30-2016 10-K
32 08-08-2016 06-30-2016 10-Q
33 05-06-2016 03-31-2016 10-Q
34 02-08-2016 12-31-2015 10-Q
35 11-25-2015 09-30-2015 10-K
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-06-2015 12-31-2014 10-Q
39 11-25-2014 09-30-2014 10-K
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-hold-on-raymond-james-finl-lowers-price-target-to-126

TD Cowen analyst Bill Katz maintains Raymond James Finl (NYSE:RJF) with a Hold and lowers the price target from $131 to $126.

 b-of-a-securities-maintains-buy-on-raymond-james-finl-lowers-price-target-to-141

B of A Securities analyst Mark McLaughlin maintains Raymond James Finl (NYSE:RJF) with a Buy and lowers the price target fro...

 keefe-bruyette--woods-maintains-market-perform-on-raymond-james-finl-lowers-price-target-to-131

Keefe, Bruyette & Woods analyst Kyle Voigt maintains Raymond James Finl (NYSE:RJF) with a Market Perform and lowers the ...

 raymond-james-finl-q2-2024-adj-eps-231-inline-sales-3120b-miss-3143b-estimate

Raymond James Finl (NYSE:RJF) reported quarterly Adj earnings of $2.31 per share which met the analyst consensus estimate. The ...

 citigroup-maintains-neutral-on-raymond-james-finl-raises-price-target-to-132

Citigroup analyst Christopher Allen maintains Raymond James Finl (NYSE:RJF) with a Neutral and raises the price target from ...

 jmp-securities-reiterates-market-perform-on-raymond-james-finl

JMP Securities analyst Devin Ryan reiterates Raymond James Finl (NYSE:RJF) with a Market Perform.

 morgan-stanley-maintains-equal-weight-on-raymond-james-finl-raises-price-target-to-123

Morgan Stanley analyst Michael Cyprys maintains Raymond James Finl (NYSE:RJF) with a Equal-Weight and raises the price targe...

 cramer-isnt-knocking-this-pharma-firm-anymore-as-a-matter-of-fact-im-going-in

Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to J...

 td-cowen-maintains-market-perform-on-raymond-james-finl-raises-price-target-to-131

TD Cowen analyst Bill Katz maintains Raymond James Finl (NYSE:RJF) with a Market Perform and raises the price target from $1...

 raymond-james-financial-names-paul-shoukry-president-and-to-become-ceo-successor-sometime-during-fiscal-2025-announces-additional-key-leadership-changes

The Raymond James Financial (NYSE:RJF) Board of Directors announced today that as part of its multi-year succession planning pr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION